Ascendis Pharma A/S vs Stitch Fix Inc — how do they compare? Ascendis Pharma A/S trades at $254.5 (market cap $16.67B), while Stitch Fix Inc trades at $3.79 (market cap $497.68M). The key difference: Ascendis Pharma A/S is far larger — about 33.5× Stitch Fix Inc's market cap, and Ascendis Pharma A/S is trading nearer its 52-week high, Stitch Fix Inc nearer its low. Which is the better fit depends on your goals.
| ASND | SFIX | |
|---|---|---|
Market Cap | $16.67B | $497.68M |
Sector | Health | Consumer Cyclical |
52-Week High | $277.18 | $5.83 |
52-Week Low | $189.74 | $3.06 |
Enterprise Value | $17.04B | $385.40M |
Trailing returns across standard periods
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →Stitch Fix Inc offers personal style service for men and women. The company engages in delivering one-to-one personalization to clients through the combination of data science and human judgment. It provides a shipment service called A FIX where the stylist's hand selects items from several merchandises with analysis of client and merchandise data to provide a personalized shipment of apparel, shoes, and accessories suited to the client's needs. The company offers products across categories, brands, product types and price points including Women's, Petite, Maternity, Men's and Plus. It also offers various product types, including denim, dresses, blouses, skirts, shoes, jewelry and handbags, and sells merchandise across various range of price points.
Read more on SFIX →